IL6ST
Interleukin-6 receptor subunit beta
Also known as: CD130, GP130, IL-6RB, IL6RB_HUMAN, sGP130
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P40189
- Gene
- IL6ST
- Ensembl
- ENSG00000134352
- Chromosome
- 5
- Canonical length
- 918 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins
- Subcellular location
- Golgi apparatus,Plasma membrane
- Secretome location
- Secreted to blood
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a signal transducer shared by many cytokines, including interleukin 6 (IL6), ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), and oncostatin M (OSM). This protein functions as a part of the cytokine receptor complex. The activation of this protein is dependent upon the binding of cytokines to their receptors. vIL6, a protein related to IL6 and encoded by the Kaposi sarcoma-associated herpesvirus, can bypass the interleukin 6 receptor (IL6R) and directly activate this protein. Knockout studies in mice suggest that this gene plays a critical role in regulating myocyte apoptosis. Alternatively spliced transcript variants have been described. A related pseudogene has been identified on chromosome 17. [provided by RefSeq, May 2014]
Canonical amino-acid sequenceUniProt
918 residues, UniProt reviewed canonical sequence.
>P40189|IL6ST
1 MLTLQTWLVQ ALFIFLTTES TGELLDPCGY ISPESPVVQL HSNFTAVCVL KEKCMDYFHV
61 NANYIVWKTN HFTIPKEQYT IINRTASSVT FTDIASLNIQ LTCNILTFGQ LEQNVYGITI
121 ISGLPPEKPK NLSCIVNEGK KMRCEWDGGR ETHLETNFTL KSEWATHKFA DCKAKRDTPT
181 SCTVDYSTVY FVNIEVWVEA ENALGKVTSD HINFDPVYKV KPNPPHNLSV INSEELSSIL
241 KLTWTNPSIK SVIILKYNIQ YRTKDASTWS QIPPEDTAST RSSFTVQDLK PFTEYVFRIR
301 CMKEDGKGYW SDWSEEASGI TYEDRPSKAP SFWYKIDPSH TQGYRTVQLV WKTLPPFEAN
361 GKILDYEVTL TRWKSHLQNY TVNATKLTVN LTNDRYLATL TVRNLVGKSD AAVLTIPACD
421 FQATHPVMDL KAFPKDNMLW VEWTTPRESV KKYILEWCVL SDKAPCITDW QQEDGTVHRT
481 YLRGNLAESK CYLITVTPVY ADGPGSPESI KAYLKQAPPS KGPTVRTKKV GKNEAVLEWD
541 QLPVDVQNGF IRNYTIFYRT IIGNETAVNV DSSHTEYTLS SLTSDTLYMV RMAAYTDEGG
601 KDGPEFTFTT PKFAQGEIEA IVVPVCLAFL LTTLLGVLFC FNKRDLIKKH IWPNVPDPSK
661 SHIAQWSPHT PPRHNFNSKD QMYSDGNFTD VSVVEIEAND KKPFPEDLKS LDLFKKEKIN
721 TEGHSSGIGG SSCMSSSRPS ISSSDENESS QNTSSTVQYS TVVHSGYRHQ VPSVQVFSRS
781 ESTQPLLDSE ERPEDLQLVD HVDGGDGILP RQQYFKQNCS QHESSPDISH FERSKQVSSV
841 NEEDFVRLKQ QISDHISQSC GSGQMKMFQE VSAADAFGPG TEGQVERFET VGMEAATDEG
901 MPKSYLPQTV RQGGYMPQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL6ST can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 182 nTPM
Expression across tissuesHPA
Tissue
- placenta: 182 nTPM
- liver: 121 nTPM
- adipose tissue: 86 nTPM
- parathyroid gland: 80 nTPM
- cervix: 72 nTPM
- urinary bladder: 68 nTPM
Single-cell type
- endometrial glandular cells: 1,204 nCPM
- microglia: 759 nCPM
- platelets: 682 nCPM
- vascular endothelial cells: 606 nCPM
- lymphatic endothelial cells: 586 nCPM
- medullary thymic epithelial cells: 514 nCPM
Immune cell
- naive CD4 T-cell: 23 nTPM
- naive CD8 T-cell: 7.2 nTPM
- memory CD4 T-cell: 5.8 nTPM
- total PBMC: 5.1 nTPM
- classical monocyte: 4.9 nTPM
- T-reg: 4.8 nTPM
Brain region
- white matter: 119 nTPM
- medulla oblongata: 115 nTPM
- spinal cord: 112 nTPM
- pons: 109 nTPM
- hypothalamus: 107 nTPM
- cerebral cortex: 97 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IL6ST.
Disease | AllUniProt
Conditions IL6ST is implicated in, by any mechanism.
- Hyper-IgE syndrome 4A, autosomal dominant, with recurrent infections (HIES4A) MIM:619752
- Hyper-IgE syndrome 4B, autosomal recessive, with recurrent infections (HIES4B) MIM:618523
- Stuve-Wiedemann syndrome 2 (STWS2) MIM:619751
- Immunodeficiency 94 with autoinflammation and dysmorphic facies (IMD94) MIM:619750
Disease | GeneticClinVar
24 pathogenic / likely-pathogenic of 647 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hyper-IgE recurrent infection syndrome 4A, autosomal dominant
- Stuve-Wiedemann syndrome 2
- Hyper-IgE recurrent infection syndrome 4, autosomal recessive
- Stuve-Wiedemann syndrome
- Immunodeficiency 94 with autoinflammation and dysmorphic facies
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.23
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.06
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell surface receptor signaling pathway via STAT
- ciliary neurotrophic factor-mediated signaling pathway
- cytokine-mediated signaling pathway
- glycogen metabolic process
- interleukin-11-mediated signaling pathway
- interleukin-27-mediated signaling pathway
- interleukin-6-mediated signaling pathway
- intestinal epithelial cell development
- leukemia inhibitory factor signaling pathway
- negative regulation of apoptotic process
- negative regulation of interleukin-6-mediated signaling pathway
- negative regulation of neuron apoptotic process
- oncostatin-M-mediated signaling pathway
- positive regulation of acute inflammatory response
- positive regulation of adaptive immune response
- positive regulation of astrocyte differentiation
- positive regulation of cardiac muscle hypertrophy
- positive regulation of cell population proliferation
- positive regulation of Notch signaling pathway
- positive regulation of osteoblast differentiation
- positive regulation of platelet aggregation
- positive regulation of T cell proliferation
- positive regulation of vascular endothelial growth factor production
- response to cytokine
- T-helper 17 cell lineage commitment
Molecular functions
- ciliary neurotrophic factor receptor activity
- ciliary neurotrophic factor receptor binding
- coreceptor activity
- cytokine binding
- cytokine receptor activity
- growth factor binding
- identical protein binding
- interleukin-11 binding
- interleukin-11 receptor activity
- interleukin-27 receptor activity
- interleukin-6 receptor activity
- protein tyrosine kinase activator activity
- scaffold protein binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IL6ST in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL6ST as an antibody target. Whether an autoantibody or antibody against IL6ST could matter depends on whether native IL6ST is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL6ST is annotated at the cell surface, where native IL6ST is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IL6ST as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...